Novartis AG

Novartis AG

• Actavis buying Warner Chilcott in $8.5B deal

  Actavis is buying Warner Chilcott in an all-stock deal valued at about $8.5 billion that would create the third-biggest specialty pharmaceutical ... 

• 

  Pfizer 1Q profit up, but drugmaker cuts outlook

  Pfizer Inc.'s first-quarter net income rose 53 percent despite falling sales, mainly because the world's second-largest drugmaker took big charges a ... 

• 

  Novartis posts profit gain thanks to new drugs

  Swiss pharmaceutical company Novartis AG reported a 6.7 percent increase in profit for the first quarter Wednesday, boosted by new products and ... 

• 

  India's rejection of drug patent could reverberate

  The India Supreme Court's rejection of a patent for an improved version of a costly cancer drug by Novartis AG could have big implications for the ... 

• 

  Drug maker Novartis loses India patent battle

  India's Supreme Court on Monday rejected drug maker Novartis AG's attempt to patent an updated version of a cancer drug in a landmark decision that ... 

• 

  India's top court to deliver Novartis judgment

  India's Supreme Court is to rule Monday on a landmark patent case involving Swiss drugmaker Novartis AG that focuses on demands by major companies ... 

• 

  India rejects Bayer plea against cheap cancer drug

  India's patent appeals office has rejected Bayer AG's plea to stop the production of a cheaper generic version of a patented cancer drug in a ruling ... 

• 

  Swiss voters approve tough limits on bosses' pay

  Swiss voters voiced their anger at perceived corporate greed Sunday by approving a plan to boost shareholders' say on executive pay. Some 67.9 percent ... 

• 

  Novartis chairman foregoes $78 million payout

  Swiss drugmaker Novartis AG has agreed with its outgoing chairman to scrap plans for a farewell non-compete deal that could have netted him up to 72 ... 

• 

  Novartis Q4 net profit rebounds to $2.1 billion

  Swiss drug maker Novartis AG reported a jump in fourth-quarter net profit to $2.08 billion on Wednesday, citing the lack of a $900-million one-time ... 

• 

  Indian court to rule on generic drug industry

  From Africa's crowded AIDS clinics to the malarial jungles of Southeast Asia, the lives of millions of ill people in the developing world are hanging ... 

• 

  J&J board picks CEO to replace retiring chairman

  Johnson & Johnson Chairman Bill Weldon will step down from that post in late December and the world's biggest maker of health products has picked new ...